Skip to main content
. 2024 Feb 14;24:100352. doi: 10.1016/j.lansea.2024.100352

Table 1.

Characteristics of patients in Cohorts 1–4.

Cohort 1 (n = 1379) Cohort 2 (n = 591) Cohort 3 (n = 96) Cohort 4 (n = 211)
Data source India India India USA
Age, years 62.4 (23–92) 61.7 (21–90) 58.6 (24–86) 67.96 (24–87)
Sex
 Male 905 (65.6%) 356 (60.2%) 64 (66.7%) 135 (63.9%)
 Female 474 (34.4%) 235 (39.8%) 32 (33.3%) 76 (36.1%)
Smoking
 Never 736 (54.4%) 356 (60.2%) 67 (69.8%) 48 (22.7%)
 Smoker 643 (46.6%) 235 (39.8%) 29 (30.2%) 163 (77.3%)
Histology
 Adenocarcinoma 903 (65.5%) 408 (69.0%) 93 (96.9%) 172 (81.5%)
 Squamous cell carcinoma 259 (18.8%) 101 (17.1%) 3 (3.1%) 35 (16.6%)
 Others 217 (15.7%) 82 (13.9%) 0 (0.0%) 4 (1.9%)
EGFR genotype
 Wild-type 699 (50.7%) 286 (48.4%) 69 (71.9%) 133 (63%)
 Mutant 680 (49.3%) 305 (51.6%) 25 (28.1%) 38 (18%)
 NA 0 0 0 40 (19%)

The patient characteristics are unavailable for Cohort 5.